Mahamet GV 2mg/500mg/0.2mg Tablet SR
Marketer
Elgoog Health Series
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Mahamet GV 2mg/500mg/0.2mg Tablet SR
Glyciphage-GV 2mg/500mg/0.2mg Extended-Release tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Administer Glyciphage-GV with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and appropriate countermeasures. Maintain regular meals and carry a quick-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any prior heart conditions before initiating treatment. Pregnant or breastfeeding individuals should consult their doctor. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.
Uses of Mahamet GV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Mahamet GV 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Mahamet GV 2mg/500mg/0.2mg Sustained-Release tablets on an empty stomach.
Common Side effects of Mahamet GV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Mahamet GV 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Mahamet GV 2mg/500mg/0.2mg Tablet SR on an empty stomach.
How Mahamet GV 2mg/500mg/0.2mg Tablet SR works:
Each Mahamet GV SR tablet (2mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Mahamet GV 2mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Mahamet GV 2mg/500mg/0.2mg SR Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Mahamet GV 2mg/500mg/0.2mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney impairment should likely avoid Mahamet GV 2mg/500mg/0.2mg Tablet SR, as its use may be unsafe. Medical advice is recommended. The use of Mahamet GV 2mg/500mg/0.2mg Tablet SR is discouraged in those with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Mahamet GV 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for those with mild to moderate hepatic dysfunction; however, the medication is contraindicated in patients with severe liver disease.
What if you forget to take Mahamet GV 2mg/500mg/0.2mg Tablet SR :
Should you forget to take your Mahamet GV 2mg/500mg/0.2mg SR Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.
Facts to Know About Mahamet GV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently